table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Targeted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Targeted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Targeted Drug Overall Market Size
2.1 Global Cancer Targeted Drug Market Size: 2022 VS 2030
2.2 Global Cancer Targeted Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Targeted Drug Players in Global Market
3.2 Top Global Cancer Targeted Drug Companies Ranked by Revenue
3.3 Global Cancer Targeted Drug Revenue by Companies
3.4 Top 3 and Top 5 Cancer Targeted Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Targeted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Targeted Drug Players in Global Market
3.6.1 List of Global Tier 1 Cancer Targeted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Targeted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Targeted Drug Market Size Markets, 2022 & 2030
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Cancer Targeted Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Targeted Drug Revenue, 2018-2023
4.2.2 By Type - Global Cancer Targeted Drug Revenue, 2023-2030
4.2.3 By Type - Global Cancer Targeted Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Targeted Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Targeted Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Targeted Drug Revenue, 2018-2023
5.2.2 By Application - Global Cancer Targeted Drug Revenue, 2023-2030
5.2.3 By Application - Global Cancer Targeted Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Targeted Drug Market Size, 2022 & 2030
6.2 By Region - Global Cancer Targeted Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Targeted Drug Revenue, 2018-2023
6.2.2 By Region - Global Cancer Targeted Drug Revenue, 2023-2030
6.2.3 By Region - Global Cancer Targeted Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Targeted Drug Revenue, 2018-2030
6.3.2 US Cancer Targeted Drug Market Size, 2018-2030
6.3.3 Canada Cancer Targeted Drug Market Size, 2018-2030
6.3.4 Mexico Cancer Targeted Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Targeted Drug Revenue, 2018-2030
6.4.2 Germany Cancer Targeted Drug Market Size, 2018-2030
6.4.3 France Cancer Targeted Drug Market Size, 2018-2030
6.4.4 U.K. Cancer Targeted Drug Market Size, 2018-2030
6.4.5 Italy Cancer Targeted Drug Market Size, 2018-2030
6.4.6 Russia Cancer Targeted Drug Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Targeted Drug Market Size, 2018-2030
6.4.8 Benelux Cancer Targeted Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Targeted Drug Revenue, 2018-2030
6.5.2 China Cancer Targeted Drug Market Size, 2018-2030
6.5.3 Japan Cancer Targeted Drug Market Size, 2018-2030
6.5.4 South Korea Cancer Targeted Drug Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Targeted Drug Market Size, 2018-2030
6.5.6 India Cancer Targeted Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Targeted Drug Revenue, 2018-2030
6.6.2 Brazil Cancer Targeted Drug Market Size, 2018-2030
6.6.3 Argentina Cancer Targeted Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Targeted Drug Revenue, 2018-2030
6.7.2 Turkey Cancer Targeted Drug Market Size, 2018-2030
6.7.3 Israel Cancer Targeted Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Targeted Drug Market Size, 2018-2030
6.7.5 UAE Cancer Targeted Drug Market Size, 2018-2030
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Cancer Targeted Drug Major Product Offerings
7.1.4 Bayer Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Cancer Targeted Drug Major Product Offerings
7.2.4 Eisai Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News
7.3 Zelgen
7.3.1 Zelgen Corporate Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Cancer Targeted Drug Major Product Offerings
7.3.4 Zelgen Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Cancer Targeted Drug Major Product Offerings
7.4.4 Cipla Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News
7.5 Natco Pharma
7.5.1 Natco Pharma Corporate Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Cancer Targeted Drug Major Product Offerings
7.5.4 Natco Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cancer Targeted Drug Major Product Offerings
7.6.4 AstraZeneca Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Targeted Drug Major Product Offerings
7.7.4 Novartis Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Cancer Targeted Drug Major Product Offerings
7.8.4 Roche Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.8.5 Roche Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Targeted Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cancer Targeted Drug Major Product Offerings
7.10.4 Pfizer Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News
7.11 BEACON Pharma
7.11.1 BEACON Pharma Corporate Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Cancer Targeted Drug Major Product Offerings
7.11.4 BEACON Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Corporate Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Cancer Targeted Drug Major Product Offerings
7.12.4 Jiangxi Shanxiang Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News
7.13 Yao Pharma
7.13.1 Yao Pharma Corporate Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Cancer Targeted Drug Major Product Offerings
7.13.4 Yao Pharma Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News
7.14 CSPC
7.14.1 CSPC Corporate Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Cancer Targeted Drug Major Product Offerings
7.14.4 CSPC Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Corporate Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Cancer Targeted Drug Major Product Offerings
7.15.4 CHIATAI Tianqing Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News
7.16 Simcere
7.16.1 Simcere Corporate Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Cancer Targeted Drug Major Product Offerings
7.16.4 Simcere Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
